VR in Healthcare Beyond Training: Therapy and Patient Care

Patient-facing virtual reality has moved from experimental distraction techniques into regulated medical tools that address chronic pain, PTSD and rehabilitation needs. AppliedVR secured FDA authorization for EaseVRx in November 2021, marking the first prescription virtual reality treatment specifically for chronic lower back pain; the system was later rebranded as RelieVRx and is now available by physician order in the United States.

These clinical applications differ sharply from consumer wellness headsets that promise general relaxation. Regulated digital therapeutics must demonstrate safety and efficacy through rigorous trials, while exposure therapy leverages controlled virtual environments to treat specific psychiatric conditions. Procurement remains challenging because many hospital systems still classify VR hardware as capital equipment rather than a reimbursable service, and insurance coverage varies widely across states.

Early Pain Distraction Research Set the Stage

SnowWorld, developed at the University of Washington by Hunter Hoffman and David Patterson, has been used for burn-wound pain distraction since the early 2000s. The immersive icy canyon environment proved that virtual reality could reduce perceived pain intensity by up to 50 percent during wound care procedures without additional medication. Patients reported feeling less anxiety and needed fewer opioid doses when immersed in the game-like world. The approach demonstrated that VR could directly influence sensory processing in the brain rather than merely distracting attention.

RelieVRx Brings FDA Oversight to Chronic Pain

AppliedVR received FDA authorization for EaseVRx in November 2021, the first prescription VR treatment for chronic lower back pain. The eight-week program combines cognitive behavioral therapy modules with relaxation and mindfulness exercises delivered through a standalone headset. Patients complete daily 2- to 16-minute sessions that teach pain management skills while providing immediate biofeedback on posture and breathing. Clinical trials showed statistically significant reductions in pain intensity and interference with daily activities compared with a sham control.

Bravemind Delivers Exposure Therapy for PTSD

Bravemind, built at USC Institute for Creative Technologies by Albert Rizzo, is used for VR exposure therapy for PTSD in VA and military settings. Clinicians can customize virtual scenarios ranging from convoy operations in desert landscapes to urban combat zones, gradually increasing intensity based on patient tolerance. Sessions typically last 45 minutes and are conducted weekly for eight to twelve weeks under direct supervision of a licensed therapist. The system records physiological data including heart rate variability to help therapists adjust exposure levels in real time.

XRHealth Demonstrates Virtual Telehealth Clinics

XRHealth runs VR-based telehealth clinics that connect patients with licensed therapists for remote sessions covering pain management, physical rehabilitation and cognitive behavioral therapy. Patients receive a pre-configured headset shipped to their home along with instructions for connecting to live video appointments. Therapists can see exactly what the patient sees inside the virtual environment and provide real-time guidance during exercises. A typical course of care runs several weeks of scheduled sessions before insurance.

Wellness Apps Versus Regulated Digital Therapeutics

Consumer wellness applications such as meditation or breathing exercises carry no medical claims and require no clinical evidence. In contrast, FDA-regulated digital therapeutics must undergo the same review process as pharmaceutical drugs, including randomized controlled trials that demonstrate statistically significant improvements over placebo. Exposure therapy occupies a middle ground where the virtual environment serves as a tool within an established psychotherapeutic framework rather than a standalone treatment. The distinction matters because only regulated products can be prescribed and reimbursed by insurance.

Procurement and Reimbursement Remain Significant Barriers

Hospital procurement departments often struggle to categorize VR systems because they do not fit neatly into existing medical device budgets. An enterprise headset bundle with software licenses typically lands in the low thousands of dollars per unit. Without dedicated reimbursement codes, many facilities rely on philanthropy or research grants to fund initial deployments. The VA has been an early adopter precisely because its integrated payer-provider model removes many of these financial obstacles.

• RelieVRx requires a physician prescription and eight weeks of daily sessions to achieve clinically meaningful pain reduction.
• Bravemind sessions are always supervised by licensed therapists trained in prolonged exposure protocols.
• SnowWorld continues to be used in burn units because it requires minimal training for nursing staff.
• XRHealth clinics bill insurance using existing remote therapeutic monitoring codes established in 2022.
• FDA authorization demands evidence from randomized controlled trials.
• Reimbursement rates for VR-assisted therapy vary widely by state and insurer.

Virtual reality has proven its clinical value in targeted areas of patient care, yet scaling these solutions across fragmented healthcare systems will require clearer reimbursement pathways and standardized training programs for providers. The technology works best when integrated thoughtfully into existing therapeutic relationships rather than positioned as a standalone cure.